lipid-lowering agent

出典: meddic

antilipemic agentantilipemic drughypolipidemichypolipidemic agenthypolipidemic drughypolipidemicslipid-lowering drug

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals.
  • Fu Q, Li YP, Gao Y, Yang SH, Lu PQ, Jia M, Zhang LR.SourceDepartment of Pharmacology, School of Medicine, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, China.
  • European journal of clinical pharmacology.Eur J Clin Pharmacol.2013 Jun;69(6):1269-74. doi: 10.1007/s00228-012-1453-9. Epub 2012 Dec 22.
  • PURPOSE: There is significant inter-individual variability in the lipid-lowering effects of atorvastatin and simvastatin. Our goal was to investigate the impact of SLCO1B1 genetic polymorphism on the lipid-lowering effects of atorvastatin and simvastatin.METHODS: We recruited 363 unrelated hyperlipi
  • PMID 23263738
  • Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements.
  • Tran AT, Straand J, Dalen I, Birkeland KI, Claudi T, Cooper JG, Meyer HE, Jenum AK.AbstractBACKGROUND: Ethnic minority groups have higher prevalence of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). We assessed general practitioners' (GPs') performance with respect to the pharmacological prevention of CVD in patients with T2DM from different ethnic backgrounds in Oslo.
  • BMC health services research.BMC Health Serv Res.2013 May 20;13(1):182. [Epub ahead of print]
  • BACKGROUND: Ethnic minority groups have higher prevalence of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). We assessed general practitioners' (GPs') performance with respect to the pharmacological prevention of CVD in patients with T2DM from different ethnic backgrounds in Oslo.M
  • PMID 23688317

和文文献

  • Inhibition of Smooth Muscle Cell Proliferation by Ezetimibe via the Cyclin D1-MAPK Pathway
  • Rhabdomyolysis Developing Secondary to Atorvastatin Therapy in a Patient with Liver Cirrhosis
  • Effect of Probucol on Antioxidant Properties of HDL in Patients with Heterozygous Familial Hypercholesterolemia

関連リンク

Clinical and research information on drug-induced liver injury. ... The lipid lowering agents are used to treat hypercholesterolemia and dyslipidemias. These agents are some of the most frequently used medications in the ...
Lipid-Lowering Agents, Statins: Dosing, Uses, Side Effects, Interactions, Patient Handouts, Pricing and more from Medscape Reference ... Medscape's clinical reference is the most authoritative and accessible point-of-care medical ...

関連画像

 lipid-lowering agent in violation ofLOSEROL is a lipid lowering agent with Lipid Regulating Agents; Lipid Regulating Home > Lipid lowering agent > Rovista 10mg Which lipid-lowering agent decreases TAG's Lipid Lowering Agent Archives - Renata


★リンクテーブル★
リンク元高脂血症治療薬」「lipid-lowering drug」「hypolipidemic」「抗高脂血症剤」「antilipemic drug
関連記事agent」「age」「lip」「lowering」「lipid

高脂血症治療薬」

  [★]

lipid-lowering drug, lipid-lowering agent
脂質異常症
  Cho TG LDL-C↓ HDL-C↑ TG↓ 副作用
HMG-CoA還元酵素阻害薬 Choの合成阻害
→LDL受容体増加
    発疹、胃不快感、肝障害、
筋肉痛、筋脱力、横紋筋融解症
フィブラート系薬物   VLDL産生抑制
→VLDL,IDL異化促進
単独で、横紋筋融解症
腹痛、下痢、嘔吐などの腹部症状、肝障害
ニコチン酸系薬 VLDL分泌抑制 皮膚、特に顔面および上半身の紅潮、掻痒感
肝障害、胃腸障害、耐糖能の悪化、尿酸値上昇
陰イオン交換樹脂系薬物 胆汁酸再吸収抑制       腹部膨満感、便秘、肝障害
ビフェニル化合物 Choの胆汁排泄促進       肝障害、胃腸障害、耐糖能の悪化、尿酸値上昇発疹
まれにQT延長にともなう不整脈
EPA製剤   VLDL産生抑制
→VLDL異化促進
    胃部不快感、腹痛、下痢などの腹部症状
肝障害、出血傾向

高脂血症治療薬一覧

lipid-lowering drug」

  [★]

antilipemic agentantilipemic drughypolipidemichypolipidemic agenthypolipidemic drughypolipidemicslipid-lowering agent


hypolipidemic」

  [★]

  • adj.
  • 脂質低下性の、脂質低下の
  • n.
antilipemic agentantilipemic drughypolipidemic agenthypolipidemic drughypolipidemicslipid-loweringlipid-lowering agentlipid-lowering drug


抗高脂血症剤」

  [★]

lipid-lowering druglipid-lowering agenthypolipidemic drug
抗高脂血症薬抗脂血剤抗脂血薬抗高脂血薬抗高脂血剤高脂血症薬高脂血症治療薬


antilipemic drug」

  [★]

antilipemic agenthypolipidemichypolipidemic agenthypolipidemic drughypolipidemicslipid-lowering agentlipid-lowering drug


agent」

  [★]

  • n.
  • 代行者、代理人。代理業者
  • 政府職員、官吏
  • ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、~剤。病原体
agonistagonisticattorneydelegatedrugetiologic agentfomesfomitesmediatorpathogenpathogenicpharmaceutical preparationvectorvehicle

WordNet   license wordnet

「a substance that exerts some force or effect」

WordNet   license wordnet

「a businessman who buys or sells for another in exchange for a commission」
factor, broker

WordNet   license wordnet

「any agent or representative of a federal agency or bureau」
federal agent

WordNet   license wordnet

「a representative who acts on behalf of other persons or organizations」

WordNet   license wordnet

「an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"」

PrepTutorEJDIC   license prepejdic

「『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員」


age」

  [★]

  • n.
  • v.
  • 加齢する、熟成する
agedageingagingyear old

WordNet   license wordnet

「how long something has existed; "it was replaced because of its age"」

WordNet   license wordnet

「a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld"」
eld

WordNet   license wordnet

「begin to seem older; get older; "The death of his wife caused him to age fast"」

WordNet   license wordnet

「make older; "The death of his child aged him tremendously"」

PrepTutorEJDIC   license prepejdic

「〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる」


lip」

  [★]

  • n.

WordNet   license wordnet

「(botany) either of the two parts of a bilabiate corolla or calyx」

WordNet   license wordnet

「either the outer margin or the inner margin of the aperture of a gastropod''s shell」

WordNet   license wordnet

「either of two fleshy folds of tissue that surround the mouth and play a role in speaking」

PrepTutorEJDIC   license prepejdic

「〈C〉『くちびる』,口もと / 《複数形で》(発音器官としての)くちびる,口 / 〈U〉《俗》生意気な言葉 / 〈C〉(容器などの)口,へり,縁;(峡谷・火山などの)口 / 〈C〉(植物の)唇弁(しんべん)」


lowering」

  [★]

  • n.
declinedecreasedepressiondropfalllowerreduction

WordNet   license wordnet

「the act of causing something to move to a lower level」
letting down

WordNet   license wordnet

「the act of causing to become less」

PrepTutorEJDIC   license prepejdic

「低くする,低下させる;堕落させる」

PrepTutorEJDIC   license prepejdic

「(空模様が)険悪な,荒れ模様の / しかめっつらの,(顔つきが)不機嫌な」


lipid」

  [★] 脂質

WordNet   license wordnet

「an oily organic compound insoluble in water but soluble in organic solvents; essential structural component of living cells (along with proteins and carbohydrates)」
lipide, lipoid

PrepTutorEJDIC   license prepejdic

「脂質,あぶら」




★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡